MPH Evan R. Myers MD

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The appropriate management of breast cancer risk in BRCA mutation carriers following ovarian cancer diagnosis remains unclear. We sought to determine the survival benefit and cost effectiveness of risk-reducing mastectomy (RRM) among women with BRCA1/2 mutations following stage II–IV ovarian cancer. We constructed a decision model from a third-party payer(More)
  • 1